Skip to search formSkip to main contentSkip to account menu

methoxyadiantifoline

Known as: 4H-Dibenzo(de,g)quinoline, 9-(4,5-dimethoxy-2-((1,2,3,4-tetrahydro-5,6,7-trimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-5,6,6a,7-tetrahydro-1,2,3,10-tetramethoxy-6-methyl-, (S-(R*,R*))- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AlkaloidsIsoquinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: correlation between binding affinity, inhibitory potency, and antifibrotic potential.
1991
1991
Binding of bisbenzylisoquinoline alkaloids to phosphatidylcholine vesicles and alveolar macrophages: relationship between binding affinity and antifibrogenic potential of these drugs.
A group of bisbenzylisoquinoline alkaloids has been shown to exhibit various degrees of effectiveness in preventing silica… 
1988
1988
Effects of methoxyadiantifoline on the physiologic properties of rat atria
Methoxyadiantifoline (MAF) is a new alkaloid isolated from Thalictrum ome iense W.T. Wang. Its effects upon the physiologic… 
1988
1988
Effects of methoxyadiantifoline on coronary circulation and contractility of coronary strips
Methoxyadiantifoline(MAP) is a new alkalcid, isolated from Tha lictrum omeiense WT Wang. MAF 17μM. 50μM increased the coronary… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)